The main purpose of this legislation, known as the Nitazene Control Act of 2025, is to permanently classify a group of synthetic opioids called nitazenes as Schedule I substances under the Controlled Substances Act. This classification is intended to address the growing concern over the misuse and dangers associated with these drugs, which have been linked to increased overdose deaths. Key provisions of the Act include the formal addition of nitazenes to Schedule I, which means they are recognized as having a high potential for abuse and no accepted medical use.